at least, for the past 6 or so months, we have had some improvement in the sp, and a cap raise, and even that didn’t fall the price over. We are in a different phase with this company now. I bought a few at12.5 today….it just looks solid now. As FHC says, if we get efficacy signal in another 1-2 candidates it will surely make a difference. If its present in all 3….. we’re off. After all, we were not really expecting detectable visual changes for a year or 2 given the difficult to observe 4% annual visual loss patients average.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)